1.Genetics and renal cancer
Journal of Medical and Pharmaceutical Information 2003;0(5):7-8
Nowadays, scientists are focus on studying the hereditary basic of renal cancer in order to detect early renal cancer and initially apply some treatment methods at molecular level. There are 4 types of renal cancer: Firstly, clear cell renal carcinoma is the most common one. Secondly, hereditary papillary renal carcinoma type I (HPRC) generated from epithelium of distal convoluted tubules which was discovered by Zbar in 1944, often occurs after 40 year old. Thirdly, hereditary chromophobe renal carcinoma and oncocytome which were described by Thoenes in 1985 and by Zipell in 1942 respectively. Hereditary oncocytome was found by Weirich in 1998. Fourthly, hereditary leiomyomatosis renal cell carcinoma (HLRCC) and multiple cutaneous leiomyoma (MCL) belonging to papillary renal carcinoma type II is very malignant and metastatic
Kidney Neoplasms
;
Genetics
2.Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Jin-Shuai GUO ; Hao DING ; Peng-Yu WU ; Zi-Yi XIN ; Jian-Xin LI ; Hyon-Su JO ; Zhen-Hai MA
Chinese Medical Sciences Journal 2023;38(3):191-205
Background Kidney renal clear cell carcinoma (KIRC) is one of the most common renal malignancies with a high mortality rate. Cuproptosis, a novel form of cell death, is strongly linked to mitochondrial metabolism and is mediated by protein lipoylation, leading to a proteotoxic stress response and cell death. To date, few studies have ellucidated the holistic role of cuproptosis-related genes (CRGs) in the pathogenesis of KIRC.Methods We comprehensively and completely analyzed the RNA sequencing data and corresponding clinical information from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We screened for differentially expressed CRGs and constructed a prognostic risk model using univariate and multivariate Cox proportional regression analyses. Kaplan-Meier analysis was performed and receiver operating characteristic (ROC) curves were plotted to predict the prognosis of KIRC patients. Functional enrichment analysis was utilized to explore the internal mechanisms. Immune-related functions were analyzed using single-sample gene set enrichment analysis (ssGSEA), tumour immune dysfunction and exclusion (TIDE) scores, and drug sensitivity analysis.Results We established a concise prognostic risk model consisting of four CRGs (DBT, DLAT, LIAS and PDHB) to predict the overall survival (OS) in KIRC patients. The results of the survival analysis indicated a significantly lower OS in the high-risk group as compared to the patients in the low-risk group. The area under the time-dependent ROC curve (AUC) at 1, 3, and 5 year was 0.691, 0.618, and 0.614 in KIRC. Functional enrichment analysis demonstrated that CRGs were significantly enriched in tricarboxylic acid (TCA) cycle-related processes and metabolism-related pathways. Sorafenib, doxorubicin, embelin, and vinorelbine were more sensitive in the high-risk group.Conclusions We constructed a concise CRGs risk model to evaluate the prognosis of KIRC patients and this may be a new direction for the diagnosis and treatment of KIRC.
Humans
;
Carcinoma, Renal Cell/genetics*
;
Immunotherapy
;
Kidney
;
Kidney Neoplasms/genetics*
;
Prognosis
;
Copper
;
Apoptosis
3.Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma.
Wanting HOU ; Qiulin TANG ; Feng BI
Journal of Biomedical Engineering 2019;36(2):267-273
To evaluate the differential expression profiles of the lncRNAs, miRNAs, mRNAs and ceRNAs, and their implication in the prognosis in clear cell renal cell carcinoma (CCRCC), the large sample genomics analysis technologies were used in this study. The RNA and miRNA sequencing data of CCRCC were obtained from The Cancer Genome Atlas (TCGA) database, and R software was used for gene expression analysis and survival analysis. Cytoscape software was used to construct the ceRNA network. The results showed that a total of 1 570 lncRNAs, 54 miRNAs, and 17 mRNAs were differentially expressed in CCRCC, and most of their expression levels were up-regulated (false discovery rate < 0.01 and absolute log fold change > 2). The ceRNA regulatory network showed the interaction between 89 differentially expressed lncRNAs and 9 differentially expressed miRNAs. Further survival analysis revealed that 38 lncRNAs (including COL18A1-AS1, TCL6, LINC00475, UCA1, WT1-AS, HOTTIP, PVT1, etc.) and 2 miRNAs (including miR-21 and miR-155) were correlated with the overall survival time of CCRCC ( < 0.05). Together, this study provided us several new evidences for the targeted therapy and prognosis assessment of CCRCC.
Carcinoma, Renal Cell
;
genetics
;
Humans
;
Kidney Neoplasms
;
genetics
;
MicroRNAs
;
genetics
;
RNA, Long Noncoding
;
genetics
;
Transcriptome
5.Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells .
Xin LUO ; Junjun DONG ; Xingyue HE ; Lianju SHEN ; Chunlan LONG ; Feng LIU ; Xing LIU ; Tao LIN ; Dawei HE ; Guanghui WEI
Journal of Southern Medical University 2019;39(12):1476-1481
OBJECTIVE:
explore the expression of miR-155-5p in Wilms tumor and its effect in regulating the proliferation, migration and apoptosis of Wilms tumor cells.
METHODS:
Specimens of tumor tissues and paired adjacent tissues were obtained from 40 patients with Wilms tumor for detection of the expression levels of miR-155-5p using RT-qPCR. Wilms tumor cell line G401 was transfected with miR-155-5p mimics and miR-155-5p inhibitor to induce miR-155-5p over-expression and its inhibition, respectively, and the changes in the cell proliferation, migration and apoptosis were assessed using cell counting kit-8 (CCK-8), wound healing assay and fl ow cytometry.
RESULTS:
RT-qPCR showed that the expression of miR-155-5p decreased significantly in Wilms tumor tissues as compared with normal kidney tissues and was significantly associated with TNM stage ( < 0.05). In G401 cells, over-expression of miR-155-5p significantly inhibited the cell proliferation and migration and promoted cell apoptosis ( < 0.05), and down-regulation of miR-155-5p obviously enhanced the proliferation and migration and suppressed apoptosis of the cells ( < 0.05).
CONCLUSIONS
miR-155-5p is down-regulated in Wilms tumor and its expression level is correlated with TNM stage. miR-155-5p participates in the progression of Wilms tumor by inhibiting the proliferation and migration and promoting apoptosis of the tumor cells, and may serve as a novel biomarker for diagnosis, therapy and prognostic evaluation of Wilms tumor.
Apoptosis
;
Cell Movement
;
Cell Proliferation
;
Humans
;
Kidney Neoplasms
;
genetics
;
MicroRNAs
;
genetics
;
Neoplasm Invasiveness
;
Wilms Tumor
;
genetics
6.Papillary renal neoplasm with reverse polarity: a clinicopathological analysis.
Rong Hao JI ; Xiao Tong WANG ; Rui LI ; Sheng Bing YE ; Xuan WANG ; Heng Hui MA ; Zhen Feng LU ; Qiu RAO ; Qiu Yuan XIA
Chinese Journal of Pathology 2022;51(1):23-27
Objective: To study the clinical pathological characteristics, immunophenotype, molecular changes and prognosis of the papillary renal neoplasm with reverse polarity (PRNRP). Methods: Nine cases of PRNRP, diagnosed from 2013 to 2019, were retrieved from the Department of Pathology of Nanjing Jinling Hospital, Nanjing University School of Medicine. Histomorphology, immunophenotype and molecular genetics were analyzed with review of the literatures. Results: There were five male and four female patients, aged from 49 to 70 years, with an average age of 60.1 years. During a mean follow-up of 29 months, one patient died for other cause, and the others survived without disease. Microscopically, the tumor cells arranged in papillary structure with a fibrovascular core, the surface of which was covered with a single layer of cuboidal or columnar cells. The most prominent feature was that the tumor nuclei located at the top of the cytoplasm far from the basement membrane, and they were monotonous in size and arranged neatly with no or few nucleoli. Immunohistochemically, all nine cases of PRNRP showed diffuse positive expression of CK7 and E-cadherin, various degrees of P504s expression, and no expression of CD10 and CD117, with a Ki-67 index of 1%-3%. Unlike other papillary renal cell carcinoma, the nine cases of PRNRP all showed characteristic positive expression of GATA3. The fluorescence in situ hybridization assay showed that the majority of PRNRPs (8/9) did not have triploids on chromosomes 7 and 17. The sequencing of the KRAS gene confirmed the presence of a nonsense KRAS mutation in 8 of the 9 cases. Conclusions: PRNRP is a subtype of papillary renal cell carcinoma with characteristic morphological, immunophenotypic and molecular features, and indolent behaviors. More data are needed to define PRNRP as "carcinoma", and a definitive diagnosis of PRNRP is of great significance for proper treatment choice and accurate prognostication.
Biomarkers, Tumor
;
Carcinoma, Renal Cell/genetics*
;
Female
;
Humans
;
In Situ Hybridization, Fluorescence
;
Kidney
;
Kidney Neoplasms/genetics*
;
Male
;
Middle Aged
;
Prognosis
7.Expression of beta-human chorionic gonadotropin genes in renal cell cancer and benign renal disease tissues.
Yongguang JIANG ; Fuqing ZENG ; Chuanguo XIAO ; Junmin LIU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2003;23(3):291-293
To study the expression of beta-human chorionic gonadotropin (beta hCG) genes in renal cell carcinomas (RCC) and benign renal disease tissues, nested reverse transcription-polymerase chain reaction (RT-PCR) and restriction endonuclease analysis were employed to detect the expression of beta hCG genes in 44 cases of RCC tissues and 24 cases of benign renal disease tissues. It was found that 52% RCC samples revealed positive for beta hCG mRNA expression. Positive rate in advanced stage and poorly differentiated RCC was higher, but there was no significant difference. The positive rate of beta hCG mRNA expression was 54% in 24 cases of benign renal tissues, including 3 cases out of 6 polycystic kidneys, 7 cases out of 13 renal atrophies, 2 cases out of 2 oncocytomas and 1 case out of 2 pyonephrotic kidneys. beta 7 was most frequently transcribed subtype gene independent on the histology. These findings suggested beta hCG gene transcription is not only involved in RCC but also in benign renal diseases.
Adult
;
Biomarkers, Tumor
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
Chorionic Gonadotropin, beta Subunit, Human
;
biosynthesis
;
genetics
;
Humans
;
Kidney
;
metabolism
;
Kidney Diseases
;
genetics
;
metabolism
;
Kidney Neoplasms
;
genetics
;
metabolism
;
Polycystic Kidney Diseases
;
metabolism
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
8.Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome.
Yilin GUO ; Lu WANG ; Zhen XU ; Yangyang BAI ; Wuliang WANG ; Huifang WU ; Yingjie SUN
Chinese Journal of Medical Genetics 2022;39(5):494-498
OBJECTIVE:
To analyze clinical phenotype and genetic variants in a Chinese pedigree of hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
METHODS:
Whole exome sequencing was carried out for the proband from the pedigree. Suspected FH gene variants were validated by Sanger sequencing. Clinical manifestation and histopathological examination were used to analyze the pedigree comprehensively.
RESULTS:
The pedigree met the clinical diagnostic criteria for HLRCC syndrome. The whole exome sequencing showed that the FH gene of the proband had a heterozygous missense variant of c.1490T>C (p.F497S), which was consistent with the Sanger sequencing. The mother, daughter and son of the proband all had the heterozygous missense variant of c.1490T>C (p.F497S). According to the American Society of Medical Genetics and Genomics Classification Standards and Guidelines for Genetic Variations, c.1490T>C (p.F497S) (PM2+PP1-M+PP3+PP4) was a possible pathogenic variant. Based on our literature search, this variant was a new variant that had not been reported.
CONCLUSION
The FH gene missense variant of c.1490T>C (p.F497S) may be the cause of the HLRCC syndrome pedigree, which provides a basis for the genetic diagnosis and genetic counseling of the HLRCC syndrome.
Carcinoma, Renal Cell/genetics*
;
Humans
;
Kidney Neoplasms/genetics*
;
Leiomyomatosis/pathology*
;
Mutation
;
Neoplastic Syndromes, Hereditary
;
Pedigree
;
Phenotype
;
Skin Neoplasms
;
Uterine Neoplasms